Displaying 8441 - 8460 of 39134
February 22, 2019
Case Timeline Item
Watson Pharmaceuticals, Inc., et al. (FTC v. Actavis) (timeline item) - February 22, 2019
Date
Case Timeline Item
Benco/Schein/Patterson, In the Matter of (timeline item) - February 22, 2019
Date
February 21, 2019
FTC Approves Final Consent Order against Company and Owner Who Allegedly Made Unsupported Health Claims for Intravenously Injected Therapy Products
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges against a Texas-based marketer and seller of intravenously injected therapy products (iV...
Case Timeline Item
Benco/Schein/Patterson, In the Matter of (timeline item) - February 21, 2019
Date
File
File
Case Timeline Item
A&O Enterprises, doing business as iV Bars, and Aaron K. Roberts, In the Matter of (timeline item) - February 21, 2019
Date
File
Complaint
(939.09 KB)
File
Exhibit A: Web Capture
(9.69 MB)
File
Exhibit B: Release Form
(111.62 KB)
File
Decision and Order
(68.84 KB)
File
Letters to Commenters
(157.52 KB)
Case Timeline Item
Quincy Bioscience Holding Company (timeline item) - February 21, 2019
Date
File
Summary Order (2d Cir.)
(571.91 KB)
February 19, 2019
Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
171 0227
Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
Date
By
Rohit Chopra, Former Commissioner
Matter Number
171 0227
Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
171 0227
FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger
Date
The Federal Trade Commission will require healthcare companies Fresenius Medical Care AG & KGaA (Fresenius) and NxStage Medical, Inc. (NxStage) to divest all rights and assets related to NxStage’s...
FTC Enters Global Settlement to Resolve Reverse-Payment Charges against Teva
Date
The Federal Trade Commission has reached a global settlement resolving pending claims in three separate federal court antitrust lawsuits involving subsidiaries of pharmaceutical manufacturer Teva...
Feb01
Cmr. Wilson keynote at the GCR Live 8th Annual Antitrust Law Leaders Forum
FTC Commissioner Christine Wilson will be the keynote speaker at the GCR Live 8th Annual Antitrust Law Leaders Forum. Miami, FL
Case Timeline Item
Fresenius Medical Care and NxStage Medical, In the Matter of (timeline item) - February 19, 2019
Date
February 15, 2019
FTC Announces Annual Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates
Date
For 2019, the size-of-transaction threshold for reporting proposed mergers and acquisitions under Section 7A of the Clayton Act will adjust from $84.4 million to $90 million. Also, the 2019 thresholds...
Federal Register Notice
Revised Jurisdictional Thresholds for Section 8 of the Clayton Act; Notice
Date
Displaying 8441 - 8460 of 39134